Abstract:Peritoneal dialysis (PD)-related peritonitis is recognized as a common complication of peritoneal dialysis. Eosinophilic peritonitis is a rare type of non-infection PD-related peritonitis. Eosinophilic peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients was first reported in 1967. The cause of eosinophilic peritonitis is obscure, however it may be related to some etiologies: (1) hypersensitivity to PD materials, including catheter or dialysate; (2) bacteria, fungal or mycobacterium tuberculosis infection. Clinical investigations include asymptomatic cloudy PD effluent, fever, abdominal pain and eosinophil count elevate in PD effluent. Eosinophilic peritonitis is usually mild and self-limited. With the development of PD, more eosinophilic peritonitis cases and researches were reported. Here, we report a patient on CAPD with eosinophilic peritonitis. A 71-year-old female patient developed end-stage renal disease for 4 years and underwent CAPD (2 000 mL of 1.5% dialysis solution with four exchanges daily) for 5 months. With a history of unclean food, she was hospitalized for complaints of diarrhea, fever and cloudy peritoneal effluent for 10 days. Dialysis effluent showed an elevated white blood cell (WBC) count of 1 980 cell/mm3, with 60% polymorphonuclear cells. She was diagnosed as PD-related peritonitis, and therapy was initiated with intraperitoneal ceftazidime 1 g once a day and vancomycin 500 mg every other day. She was admitted to the hospital as the symptoms were not relieved. Her peripheral blood cell count showed a total WBC count of 6 940 cells/mm3, 36.8% eosinophil. Her PD effluent analysis showed turbidity, total WBC count of 1 480 cells/mm3, and 83% polymorphonuclear cells. Her dialysate bacteria culture, fungus culture, polymerase chain reaction for Mycobacterium tuberculosis (TB-PCR), acid-fast stain were all negative. On admission day 4, the treatments were changed to levofloxacin 200 mg once a day and vancomycin 500 mg every other day. After two weeks of antibiotics treatment, patient's symptoms were not completely improved and her dialysis effluent remained cloudy. Her blood eosinophil count elevated to 36.8%，eosinophil proportion in PD effluent>90% and PD effluent pathological findings showed eosinophil>90%. Eosinophilic peritonitis was diagnosed and a decision was made to give loratadine daily dose of 10 mg orally. The possible reasons might be the patient's allergy to some components of PD solution or connection systems in the beginning of PD, and this bacterial peritonitis episode, as well as the application of vancomycin, might lead to the fact that eosinophilic peritonitis acutely developed. For there was no improvement in clinical symptoms, loratadine was stopped, and the patient was discharged 18 days later, and received follow-up closely. Two months later, eosinophil count in blood and PD fluid decreased to normal range with no symptom. This case reminds us that in any PD-related peritonitis patient with prolonged symptoms after appropriate antibiotic therapy, and typical clinical symptoms, the diagnosis of eosinophilic peritonitis should be considered. For the count and percentage of eosinophils are not routinely reported in most laboratories, doctors need to contact the department of laboratory and the department of pathology, to confirm the cell count and proportion of eosinophils in dialysis effluent, so as to make the definite diagnosis, which can not only avoid antibiotics overuse, but also avoid antibiotics-induced eosinophilic peritonitis (such as vancomycin).

Clinical Analysis of Mucormycosis Peritonitis in a CAPD Patient

Clinical analysis of 14 cases of candidemia

Evaluation and analysis of patients with continuous ambulatory peritoneal dialysis

[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis]

Secondary peritonitis in patients treated with continuous ambulatory peritoneal dialysis

A case of Moesziomyces antarcticus peritonitis in a patient undergoing peritoneal dialysis

Fatal Gastrointestinal Mucormycosis in an Immunocompetent Patient : a Case Report and Review of the Literature

Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study.

The Clinical Characteristics and Outcome in Peritoneal Dialysis Related Enterogenic and Non-Enterogenic Peritonitis

Successful treatment of peritonitis caused by Acremonium species without catheter removal: Case report and literature review

[Clinical High Risk Factors and Prognosis of 25 Pulmonary Mucormycosis Cases].

The trend of clinical characteristic changes of CAPD-related peritonitis in a period of 8 years in a single peritoneal dialysis center

Mucormycosis in Renal Transplant Recipients: Review of 174 Reported Cases.

Characteristics Analysis, Clinical Outcome and Risk Factors for Fungal Peritonitis in Peritoneal Dialysis Patients: A 10-Year Case-Control Study

[Peritoneal Dialysis-Related Eosinophilic Peritonitis: a Case Report and Literature Review].

Peritoneal Dialysis-Associated Nontuberculous Mycobacterium Peritonitis: a Systematic Review of Reported Cases

Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship

Changes of the Peritoneal Membrane Ultrafiltration and Solute Transport Function after Peritonitis Episodes in CAPD Patients

The Causes and Countermeasures of Peritonitis Caused by Pertioneal Dialysis

Peritoneal dialysis-related peritonitis with surgical complications: report of 11 cases and review of the literature

Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: a case report and review of the literatures